These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Identification and Prognosis of Patients With Interstitial Pneumonia With Autoimmune Features. Jiwrajka N; Loizidis G; Patterson KC; Kreider ME; Johnson CR; Miller WT; Barbosa EJM; Patel N; Beers MF; Litzky LA; George MD; Porteous MK J Clin Rheumatol; 2022 Aug; 28(5):257-264. PubMed ID: 35697042 [TBL] [Abstract][Full Text] [Related]
24. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival. Hyldgaard C Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544 [TBL] [Abstract][Full Text] [Related]
26. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases]. Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111 [No Abstract] [Full Text] [Related]
27. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis. Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284 [TBL] [Abstract][Full Text] [Related]
28. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies. Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809 [TBL] [Abstract][Full Text] [Related]
29. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Ferri C; Manfredi A; Sebastiani M; Colaci M; Giuggioli D; Vacchi C; Della Casa G; Cerri S; Torricelli P; Luppi F Autoimmun Rev; 2016 Jan; 15(1):61-70. PubMed ID: 26384526 [TBL] [Abstract][Full Text] [Related]
31. Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centered retrospective cohort study. Tang HS; Tang IYK; Ho RTC; Young JKY; Lai BTL; Chung JYK; Yung AKM; Cheung CCL; Lee PML; So H Rheumatology (Oxford); 2023 Dec; ():. PubMed ID: 38096583 [TBL] [Abstract][Full Text] [Related]
32. Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Song JS; Hwang J; Cha HS; Jeong BH; Suh GY; Chung MP; Kang ES Yonsei Med J; 2015 May; 56(3):676-83. PubMed ID: 25837172 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases. Moll SA; Platenburg MGJP; Platteel ACM; Vorselaars ADM; Janssen Bonàs M; Kraaijvanger R; Roodenburg-Benschop C; Meek B; van Moorsel CHM; Grutters JC PLoS One; 2022; 17(11):e0277007. PubMed ID: 36327336 [TBL] [Abstract][Full Text] [Related]
34. Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease: Effectiveness and risk factors for death. Luo Z; Yang L; Liu S; Hu Y; Cao Z; Zhu J; Wang J; Ma Y Clin Respir J; 2020 Oct; 14(10):918-932. PubMed ID: 32460444 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312 [TBL] [Abstract][Full Text] [Related]
36. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon. Chong WH; Saha BK; Beegle S Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120 [TBL] [Abstract][Full Text] [Related]
37. Interstitial Lung Disease Associated with Connective Tissue Diseases. Peredo RA; Mehta V; Beegle S Adv Exp Med Biol; 2021; 1304():73-94. PubMed ID: 34019264 [TBL] [Abstract][Full Text] [Related]
38. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA. Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950 [TBL] [Abstract][Full Text] [Related]
39. A cohort study of interstitial lung diseases in central Denmark. Hyldgaard C; Hilberg O; Muller A; Bendstrup E Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811 [TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies. Jiang M; Dong X; Zheng Y Medicine (Baltimore); 2021 May; 100(19):e25816. PubMed ID: 34106621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]